Positioned at the frontier of cell and tissue regeneration.
The ravages of age and disease will require new cells and tissues to be regenerated.
We believe it will be possible, one day, to regenerate tissues, organs, and functionally edit our biology via gene therapies. How quickly will science fiction become science reality? Our work here will help answer that question as we make strategic investments and build a team at the forefront of our understanding of human aging. We will balance the rigors and responsibilities of the scientific process with our optimism for the future.
AgeX, a Juvenescence partner, and Sernova collaborate to utilize AgeX’s UniverCyteTM gene technology to generate immune-protected universal therapeutic cells for the treatment of type I diabetes and hemophilia A.